|
1
|
Muto J, Shirabe K, Sugimachi K and Maehara
Y: Review of angiogenesis in hepatocellular carcinoma. Hepatol Res.
45:1–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pang Q, Qu K, Bi JB, Liu SS, Zhang JY,
Song SD, Lin T, Xu XS, Wan Y, Tai MH, et al: Thrombocytopenia for
prediction of hepatocellular carcinoma recurrence: Systematic
review and meta-analysis. World J Gastroenterol. 21:7895–7906.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parikh ND, Waljee AK and Singal AG:
Downstaging hepatocellular carcinoma: A systematic review and
pooled analysis. Liver Transpl. 21:1142–1152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qi X, Liu L, Wang D, Li H, Su C and Guo X:
Hepatic resection alone versus in combination with pre- and
post-operative transarterial chemoembolization for the treatment of
hepatocellular carcinoma: A systematic review and meta-analysis.
Oncotarget. 6:36838–36859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seshadri RM, Baker EH, Templin M, Swan RZ,
Martinie JB, Vrochides D and Iannitti DA: Outcomes of surgical
resection and loco-regional therapy in patients with stage 3A
hepatocellular carcinoma: A retrospective review from the national
cancer database. HPB (Oxford). 17:964–968. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang XD, Pan LH, Wang L, Ke Y, Cao J, Yang
C, Zhong JH, Luo W, Guo J and Li LQ: Systematic review of single
large and/or multinodular hepatocellular carcinoma: Surgical
resection improves survival. Asian Pac J Cancer Prev. 16:5541–5547.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu GQ, Shi KQ, Yu HJ, He SY, Braddock M,
Zhou MT, Chen YP and Zheng MH: Optimal adjuvant therapy for
resected hepatocellular carcinoma: A systematic review with network
meta-analysis. Oncotarget. 6:18151–18161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simonetti RG, Cammà C, Fiorello F, Politi
F, D'Amico G and Pagliaro L: Hepatocellular carcinoma. A worldwide
problem and the major risk factors. Dig Dis Sci. 36:962–972. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zidan A, Scheuerlein H, Schüle S,
Settmacher U and Rauchfuss F: Epidemiological pattern of hepatitis
B and hepatitis C as etiological agents for hepatocellular
carcinoma in iran and worldwide. Hepat Mon. 12:e68942012.PubMed/NCBI
|
|
10
|
Suo GJ and Zhao ZX: Association of the
interleukin-28B gene polymorphism with development of hepatitis
virus-related hepatocellular carcinoma and liver cirrhosis: A
meta-analysis. Genet Mol Res. 12:3708–3717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park MS, Kim SK, Shin HP, Lee SM and Chung
JH: TXNDC5 gene polymorphism contributes to increased risk of
hepatocellular carcinoma in the Korean male population. Anticancer
Res. 33:3983–3987. 2013.PubMed/NCBI
|
|
12
|
Yeh CT, Liang KH, Lin CC, Chang ML, Hsu CL
and Hung CF: A single nucleotide polymorphism on the GALNT14 gene
as an effective predictor of response to chemotherapy in advanced
hepatocellular carcinoma. Int J Cancer. 134:1214–1224. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan C, Zhang W, Lu J, Wu H, Liu M and Zhu
W: DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular
carcinoma risk. Tumour Biol. 34:2827–2834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu T, Gulinaer A, Shi X, Wang F, An H,
Cui W and Li Q: Gene polymorphisms in the PI3K/AKT/mTOR signaling
pathway contribute to prostate cancer susceptibility in Chinese
men. Oncotarget. 8:61305–61317. 2017.PubMed/NCBI
|
|
15
|
Piao Y, Li Y, Xu Q, Liu JW, Xing CZ, Xie
XD and Yuan Y: Association of MTOR and AKT gene polymorphisms with
susceptibility and survival of gastric cancer. PLoS One.
10:e01364472015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He ML, Wu Y, Zhao JM, Wang Z and Chen YB:
PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma
in a Chinese population. Asian Pac J Cancer Prev. 14:5117–5122.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y,
Li N, Qi J, Wang L, Shi Y, et al: Sp1 is involved in regulation of
cystathionine γ-lyase gene expression and biological function by
PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell
Signal. 24:1229–1240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Jia L, Ma H, Li Y, Ma Z and Zhao Y:
Axl gene knockdown inhibits the metastasis properties of
hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. Tumour
Biol. 35:3809–3817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mde Almeida A, Pizzini CV, Damasceno LS,
Mde Muniz M, Almeida-Paes R, Peralta RH, Peralta JM, Rde Oliveira
V, Vizzoni AG, de Andrade CL and Zancopé-Oliveira RM: Validation of
western blot for Histoplasma capsulatum antibody detection assay.
BMC Infect Dis. 16:872016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dirani M, Nasreddine W, Abdulla F and
Beydoun A: Seizure control and improvement of neurological
dysfunction in Lafora disease with perampanel. Epilepsy Behav Case
Rep. 2:164–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Santin I, Castellanos-Rubio A, Hualde I,
Castaño L, Vitoria JC and Bilbao JR: Toll-like receptor 4 (TLR4)
gene polymorphisms in celiac disease. Tissue Antigens. 70:495–498.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki S, Hosomichi K, Yokoyama K, Tsuda
K, Hara H, Yoshida Y, Fujiwara A, Mizutani M, Shiina T, Kono T and
Hanzawa K: Primary analysis of DNA polymorphisms in the TRIM region
(MHC subregion) of the Japanese quail, Coturnix japonica. Anim Sci
J. 84:90–96. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balogh J, Victor D III, Asham EH,
Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM and Monsour
HP Jr: Hepatocellular carcinoma: A review. J Hepatocell Carcinoma.
3:41–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu X, Xin Z, Zhang W, Zheng S, Wu J, Chen
K, Wang H, Zhu X, Li Z, Duan Z, et al: A missense polymorphism in
ATF6 gene is associated with susceptibility to hepatocellular
carcinoma probably by altering ATF6 level. Int J Cancer. 135:61–68.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Zhang R, Liu Z, Li S and Xu H: The
genetic variants in the PTEN/PI3K/AKT pathway predict
susceptibility and CE(A)F chemotherapy response to breast cancer
and clinical outcomes. Oncotarget. 8:20252–20265. 2017.PubMed/NCBI
|
|
27
|
Dai X, Zhang X, Wang B, Wang C, Jiang J
and Wu C: Association between polymorphism rs678653 in human cyclin
D1 gene (CCND1) and susceptibility to cancer: A meta-analysis. Med
Sci Monit. 22:863–874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kowal A, Wiśniewski A, Kuśnierczyk P and
Jankowska R: Human leukocyte antigen (HLA)-G gene polymorphism in
patients with non-small cell lung cancer. Thorac Cancer. 6:613–619.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Azimzadeh P, Romani S, Mirtalebi H, Fatemi
SR, Kazemian S, Khanyaghma M and Mohebbi SR: Association of
co-stimulatory human B-lymphocyte antigen B7-2 (CD86) gene
polymorphism with colorectal cancer risk. Gastroenterol Hepatol Bed
Bench. 6:86–91. 2013.PubMed/NCBI
|
|
30
|
Wang MY, He J, Zhu ML, Teng XY, Li QX, Sun
MH, Wang XF, Yang YJ, Wang JC, Jin L, et al: A functional
polymorphism (rs2494752) in the AKT1 promoter region and gastric
adenocarcinoma risk in an eastern chinese population. Sci Rep.
6:200082016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu J, Lv S, An J and Lu C: Pre-miR-149
rs71428439 polymorphism is associated with increased cancer risk
and AKT1/cyclinD1 signaling in hepatocellular carcinoma. Int J Clin
Exp Med. 8:13628–13633. 2015.PubMed/NCBI
|
|
32
|
Salati U, Barry A, Chou FY, Ma R and Liu
DM: State of the ablation nation: A review of ablative therapies
for cure in the treatment of hepatocellular carcinoma. Future
Oncol. 13:1437–1448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu L, Zheng J, Chen P, Liu Q and Yuan Y:
Small nucleolar RNA ACA11 promotes proliferation, migration and
invasion in hepatocellular carcinoma by targeting the PI3K/AKT
signaling pathway. Biomed Pharmacother. 90:705–712. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gong L, Di C, Xia X, Wang J, Chen G, Shi
J, Chen P, Xu H and Zhang W: AKT/mTOR signaling pathway is involved
in salvianolic acid B-induced autophagy and apoptosis in
hepatocellular carcinoma cells. Int J Oncol. 49:2538–2548. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Z, Huang Y and Zhang J: Molecularly
targeting the PI3K-Akt-mTOR pathway can sensitize cancer cells to
radiotherapy and chemotherapy. Cell Mol Biol Lett. 19:233–242.
2014. View Article : Google Scholar : PubMed/NCBI
|
